We are live on ! Find out more
PALI icon

Palisade Bio

21 hedge funds and large institutions have $1.7M invested in Palisade Bio in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 1

200% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 3

40% more funds holding

Funds holding: 1521 (+6)

0% more ownership

Funds ownership: 0.01%0.01% (+0%)

16% less capital invested

Capital invested by funds: $2.03M → $1.7M (-$333K)

Holders
21
Holders Change
+6
Holders Change %
+40%
% of All Funds
0.32%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
6
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
ACM
1
Altium Capital Management
New York
$434K +$778K +445 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$317K
Geode Capital Management
3
Geode Capital Management
Massachusetts
$271K +$85.6K +49 +21%
SIG
4
Sargent Investment Group
Maryland
$169K +$57.7K +33 +24%
Renaissance Technologies
5
Renaissance Technologies
New York
$105K +$189K +108 New
SWIG
6
Strategic Wealth Investment Group
Kentucky
$69K
SM
7
Sabby Management
Florida
$68K
State Street
8
State Street
Massachusetts
$37K
PAG
9
Private Advisor Group
New Jersey
$37K +$12.2K +7 +23%
Northern Trust
10
Northern Trust
Illinois
$30K +$54.2K +31 New
BlackRock
11
BlackRock
New York
$29K -$14K -8 -21%
Jane Street
12
Jane Street
New York
$29K +$52.4K +30 New
Two Sigma Investments
13
Two Sigma Investments
New York
$19K +$33.2K +19 New
TSS
14
Two Sigma Securities
New York
$19K +$33.2K +19 New
GCP
15
GSA Capital Partners
United Kingdom
$14K +$24.5K +14 New
Two Sigma Advisers
16
Two Sigma Advisers
New York
$14K +$24.5K +14 New
Morgan Stanley
17
Morgan Stanley
New York
$9K +$5.24K +3 +50%
Wells Fargo
18
Wells Fargo
California
$8K
TRCT
19
Tower Research Capital (TRC)
New York
$7K +$12.2K +7 New
UBS Group
20
UBS Group
Switzerland
$5K +$3.5K +2 +67%
EWM
21
Evermay Wealth Management
Virginia
$5K +$5.24K +3 +150%
VF
22
Virtu Financial
New York
-$47K -23 Closed
HighTower Advisors
23
HighTower Advisors
Illinois
-$44K -22 Closed
Citadel Advisors
24
Citadel Advisors
Florida
-$28K -14 Closed

PALI Hedge Fund Activity: Q4 2021 in Review

21 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q4 2021, worth a combined $1.7M — down 16% from $2.03M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new PALI positions and 3 closed out — a net gain of 6 holders — while 6 added to existing stakes and 1 trimmed.

The largest buyer was Altium Capital Management, opening a new position worth an estimated $778K. The largest seller was Virtu Financial, exiting entirely with an estimated $47K sold.

  • 21 institutional investors held Palisade Bio (PALI) as of Q4 2021, up from 15 in Q3 2021.
  • Funds reported $1.7M of Palisade Bio stock for Q4 2021, down 16% quarter-over-quarter.
  • 9 funds opened new Palisade Bio positions in Q4 2021 and 3 closed out, a net change of +6 holders.
  • The largest Palisade Bio buyer in Q4 2021 was Altium Capital Management, an estimated $778K added.
  • The largest Palisade Bio seller in Q4 2021 was Virtu Financial, an estimated $47K sold.

Based on aggregated 13F filings for Q4 2021.